XI’AN, China--(BUSINESS WIRE)--Huifeng Bio-Pharmaceutical Technology, Inc. (OTCBB: HFGB) the leader in developing and producing plant extracts, pharmaceuticals and pharmaceutical raw materials in mainland China and internationally, announced today the start up of a new production facility in Xi’an, China, which will be processing an initial 1.5 tons of L-Rhamnose with a value of about $100,000 to be exported to the K.F.M. Company in Germany. L-Rhamnose, fermented and extracted from waste materials of Quercetin, is an additive used in a variety of health foods. Other Huifeng products include Troxerutin, Quercetin, Ginko Biloba and Diosmin, manufactured for use as the building blocks of drugs, dietary supplements and as additives in functional foods and beverages.
